An article was recently published in PiL nascholing entitled Post-COVID: treatment options for specific complaints. The focus is on PEM, POTS and MCAS. The (continuing education) article was created by PCNN (Post-COVID Network Netherlands) with the cooperation of various specialists from C-support, the Institute for Responsible Medicine Use, Amsterdam UMC, UMC Utrecht and an expert by experience.
PiL provides practice-oriented further training for pharmacists, general practitioners and hospital pharmacists in a combination of a trade journal, e-learning, podcast, accredited by the KNMG Medical Federation, the Dutch Association of Hospital Pharmacists (NVZA) and the KNMP Pharmacists' Organization. The article accredited further training on pharmacotherapy in primary care was published in Issue 4 (November 2024).
Healthcare professionals with a PiL membership can read the continuing education article in the magazine, but also follow the online e-learning for which accreditation of 1 point has been awarded. The e-learning contributes to more understanding, knowledge and tools in possible treatment options regarding post-COVID. After studying this:
- can you describe the different hypotheses of the pathophysiology of post-COVID
- Can you explain the criteria for diagnosing post-COVID?
- Do you recognize the most common complaints in patients with post-COVID?
- Can you explain to what extent vaccination and treatment of acute COVID-19 protect against developing post-COVID
- Can you describe the characteristics and treatment options of the symptoms and symptom clusters PEM, POTS and MCAS?
The e-learning can be accessed via the link below.
